Summary of the Third Annual Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling

Sarah A. Holstein, Zaid Al-Kadhimi, Luciano J. Costa, Theresa Hahn, Parameswaran Hari, Jens Hillengass, Allison Jacob, Nikhil C. Munshi, Stefania Oliva, Marcelo C. Pasquini, Qian Shi, Edward A. Stadtmauer, Stephanie L. Waldvogel, Philip L. McCarthy

Research output: Contribution to journalReview article

2 Scopus citations

Abstract

The third annual Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling was held on November 29, 2018, at the American Society of Hematology (ASH) annual meeting. This workshop featured the latest research focused on minimal residual disease (MRD) assessment and immune profiling (IP) in myeloma as well as discussion of the statistical and regulatory issues intrinsic to the development of MRD as a surrogate endpoint. In this report, we provide a summary of the workshop and focus on the integration of MRD and IP assessment into trial design and clinical practice.

Original languageEnglish (US)
Pages (from-to)e7-e15
JournalBiology of Blood and Marrow Transplantation
Volume26
Issue number1
DOIs
StatePublished - Jan 2020

Keywords

  • CAR T cell
  • Endpoint
  • Immune profiling
  • Minimal residual disease
  • Multiple myeloma

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Fingerprint Dive into the research topics of 'Summary of the Third Annual Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling'. Together they form a unique fingerprint.

  • Cite this

    Holstein, S. A., Al-Kadhimi, Z., Costa, L. J., Hahn, T., Hari, P., Hillengass, J., Jacob, A., Munshi, N. C., Oliva, S., Pasquini, M. C., Shi, Q., Stadtmauer, E. A., Waldvogel, S. L., & McCarthy, P. L. (2020). Summary of the Third Annual Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling. Biology of Blood and Marrow Transplantation, 26(1), e7-e15. https://doi.org/10.1016/j.bbmt.2019.09.015